News
ICCM
0.7005
-5.61%
-0.0416
HeartFlow (HTFL) Reports Q3 Loss, Beats Revenue Estimates
NASDAQ · 12h ago
IceCure Medical to Report Third Quarter 2026 Financial and Operating Results on November 18, 2026
PR Newswire · 1d ago
IceCure Medical Ltd. Granted New Patent in China for Its Cryogenic System Connector
NASDAQ · 3d ago
IceCure Medical Granted New Patent in China for Cryogenic Connector
TipRanks · 3d ago
IceCure Medical granted patent in China for its cryogenic technology platform
TipRanks · 3d ago
IceCure Medical Receives New Patent In China For Covering A Connector Used In Its Cryogenic Technology Platform
Benzinga · 3d ago
IceCure Granted New Patent in China for Its Cryogenic System Connector, Expanding Its Global IP Portfolio
PR Newswire · 3d ago
Weekly Report: what happened at ICCM last week (1102-1106)?
Weekly Report · 3d ago
IceCure Medical Sets Vote on Reverse Share Split Authority
TipRanks · 11/02 22:18
IceCure Medical Shareholders Approve Agenda After Quorum Delay
TipRanks · 11/02 21:29
Weekly Report: what happened at ICCM last week (1026-1030)?
Weekly Report · 11/02 10:12
IceCure’s PROSENSE™ Kidney Cancer Data: What a Fresh Trial Update Means for ICCM Investors
TipRanks · 10/29 16:30
IceCure Medical completes first cryoablation treatment in breast-cancer study
TipRanks · 10/27 12:40
IceCure Medical Completes Treatment Of First Patient In Its Post-Marketing Study Evaluating ProSense Cryoablation For Local Treatment Of Low-Risk Breast Cancer
Benzinga · 10/27 12:40
Weekly Report: what happened at ICCM last week (1019-1023)?
Weekly Report · 10/26 10:12
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/20 12:05
IceCure Medical begins enrollment in ProSense breast cancer cryoablation study
TipRanks · 10/20 12:00
IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
PR Newswire · 10/20 11:55
Weekly Report: what happened at ICCM last week (1012-1016)?
Weekly Report · 10/19 10:12
IceCure Showcases Strong Clinical Data and European Physician Support for ProSense Breast Cryoablation at EUSOBI 2026
TipRanks · 10/13 13:17
More
Webull provides a variety of real-time ICCM stock news. You can receive the latest news about IceCure Medical Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About ICCM
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.